ARCHIVES

Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.

This article is from The Cancer Letter archive.

Vol. 29 No. 42 | November 14, 2003

Download PDF Visit The Full Archive

Related Articles

AACR considering new office in D.C.

July 18, 2003

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

October 3, 2014

NCI, American Cancer Society Re-Evaluating Join Guidelines On Mammography Screening

September 17, 1993

In Myriad Case, the Supreme Court Hears About Tree Leaves, Baseball and Cookies

April 19, 2013

Latest Statistics Show Decline In Deaths From Breast Cancer

January 13, 1995

The March, Sept. 26: Events Planned In D.C., Around The U.S.

September 4, 1998